SCHEMBL27189401

SCHEMBL27189401

O=C(O)NCc1cccc(C(=O)Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.54
▸ CYP2D6 P10635 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ PPARG P37231 1/20 0.48
▸ MRGPRX4 Q96LA9 1/20 0.48
▸ NR1H4 Q96RI1 1/20 0.48
▸ HDAC8 Q9BY41 2/20 0.47
▸ HDAC6 Q9UBN7 2/20 0.47
▸ HDAC2 Q92769 1/20 0.47
▸ MEP1B Q16820 2/20 0.45
▸ F10 P00742 1/20 0.45
▸ MMP13 P45452 1/20 0.44
▸ ERCC1 P07992 1/20 0.44
▸ ERCC4 Q92889 1/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15600276 0.86 NR1H4 (0.61) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL8059189 0.83 CYP1A2 (0.68) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL15600277 0.83 CYP1A2 (0.59) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL18095346 0.83 TSHR (0.54) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL22083793 0.81 NOS1 (0.46) TSHRMRGPRX4NR1H4HDAC8HDAC6
SCHEMBL20489830 0.80 PRSS1 (0.58) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL15600305 0.80 LOXL2 (0.64) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL19696532 0.80 HDAC8 (0.70) MRGPRX4HDAC8HDAC6
SCHEMBL22501699 0.79 CYP1A2 (0.54) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL31160290 0.79 TSHR (0.58) CYP1A2CYP2D6CYP2C9TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4347607-A1 PENICILLIN-BINDING PROTEIN INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2024-04-10 — — EP disclosed
Send feedback